{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:17:24Z","timestamp":1779196644719,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402345"],"award-info":[{"award-number":["82402345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371998"],"award-info":[{"award-number":["82371998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1053\/j.semnuclmed.2025.03.008","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:19:12Z","timestamp":1747063152000},"page":"577-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CuII-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases"],"prefix":"10.1053","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2494-2318","authenticated-orcid":false,"given":"Weiyuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9452-6379","authenticated-orcid":false,"given":"Chongyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6670-0670","authenticated-orcid":false,"given":"Zhiqiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-2480","authenticated-orcid":false,"given":"Weijun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-1991","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0001","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04160","article-title":"Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide","volume":"13","author":"Huang","year":"2023","journal-title":"J Glob Health"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11011-021-00800-w","article-title":"Neurodegenerative disorders of Alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: An early diagnostic approach for precision treatment","volume":"37","author":"Pathak","year":"2022","journal-title":"Metab Brain Dis"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060511","article-title":"Recent research trends in neuroinflammatory and neurodegenerative disorders","volume":"13","author":"Cohen","year":"2024","journal-title":"Cells"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065487","article-title":"Neuroinflammation and oxidative stress in the pathogenesis of autism spectrum disorder","volume":"24","author":"Usui","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9478542","article-title":"Neuroinflammation as fuel for axonal regeneration in the injured vertebrate central nervous system","volume":"2017","author":"Bollaerts","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.13419","article-title":"The impact of neuroinflammation on neuronal integrity","volume":"327","author":"Tastan","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0008","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1053\/j.semnuclmed.2025.03.008_bib0009","article-title":"Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?","volume":"2","author":"Tan","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2024.111961","article-title":"New opportunities for antioxidants in amelioration of neurodegenerative diseases","volume":"221","author":"Bhandari","year":"2024","journal-title":"Mech Ageing Dev"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0011","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","article-title":"Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis","volume":"62","author":"Dasuri","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol Res"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0013","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2967\/jnumed.120.244400","article-title":"(18)F-SMBT-1: A selective and reversible PET tracer for monoamine oxidase-B imaging","volume":"62","author":"Harada","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0016","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.2967\/jnumed.121.263199","article-title":"Cyclooxygenases as potential PET imaging biomarkers to explore neuroinflammation in dementia","volume":"63","author":"Kenou","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0017","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1177\/0271678X211004146","article-title":"PET imaging of colony-stimulating factor 1 receptor: A head-to-head comparison of a novel radioligand, (11)C-GW2580, and (11)C-CPPC, in mouse models of acute and chronic neuroinflammation and a rhesus monkey","volume":"41","author":"Zhou","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0018","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.118.216747","article-title":"(18)F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: Radiation dosimetry, kinetic modeling, test-retest variability, and occupancy of the P2X7 antagonist JNJ-54175446","volume":"60","author":"Koole","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0019","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00259-019-04369-6","article-title":"(11)C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers","volume":"46","author":"Van Weehaeghe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0020","first-page":"1155","article-title":"Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential","volume":"38","author":"Fujibayashi","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nucmedbio.2011.08.008","article-title":"Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less rho0 cells and cybrids carrying MELAS mitochondrial DNA mutation","volume":"39","author":"Yoshii","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2967\/jnumed.119.230805","article-title":"Alteration of cellular reduction potential will change (64)Cu-ATSM signal with or without hypoxia","volume":"61","author":"Floberg","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0023","first-page":"58","article-title":"Focus on the controversial aspects of (64)Cu-ATSM in tumoral hypoxia mapping by PET imaging","volume":"2","author":"Colombie","year":"2015","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1073\/pnas.1116227108","article-title":"An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII","volume":"109","author":"Donnelly","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nucmedbio.2009.11.004","article-title":"Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM","volume":"37","author":"Dearling","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0026","article-title":"PET imaging for oxidative stress in neurodegenerative disorders associated with mitochondrial dysfunction","volume":"9","author":"Ikawa","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0027","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nucmedbio.2012.11.012","article-title":"A comparison of four PET tracers for brain hypoxia mapping in a rodent model of stroke","volume":"40","author":"Williamson","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0028","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0969-8051(96)00130-8","article-title":"Copper radionuclides and radiopharmaceuticals in nuclear medicine","volume":"23","author":"Blower","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0029","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00259-004-1756-x","article-title":"Dosimetry of 60\/61\/62\/64Cu-ATSM: a hypoxia imaging agent for PET","volume":"32","author":"Laforest","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jlcr.3973","article-title":"Development of an automated production process of [(64) Cu][Cu (ATSM)] for positron emission tomography imaging and theranostic applications","volume":"65","author":"Liu","year":"2022","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0031","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0032","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0033","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000479627","article-title":"Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT","volume":"78","author":"Neishi","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0034","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1212\/WNL.0000000000001588","article-title":"Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study","volume":"84","author":"Ikawa","year":"2015","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0035","article-title":"Cerebral oxidative stress in early Alzheimer's disease evaluated by (64)Cu-ATSM PET\/MRI: A preliminary study","volume":"11","author":"Okazawa","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102424","article-title":"Mitochondrial and redox modifications in early stages of Huntington's disease","volume":"56","author":"Lopes","year":"2022","journal-title":"Redox Biol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0037","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00259-011-1734-z","article-title":"Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease","volume":"38","author":"Isozaki","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0038","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mito.2009.01.011","article-title":"PET imaging of redox and energy states in stroke-like episodes of MELAS","volume":"9","author":"Ikawa","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0039","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2010-1359","article-title":"Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease","volume":"20","author":"Fodero-Tavoletti","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2967\/jnumed.115.162370","article-title":"PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease","volume":"57","author":"Torres","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0041","doi-asserted-by":"crossref","first-page":"16120","DOI":"10.1021\/ja4057807","article-title":"Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Abeta plaques","volume":"135","author":"Hickey","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0042","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1007\/s00259-022-05854-1","article-title":"In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models","volume":"49","author":"Nam","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0043","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2967\/jnumed.113.126664","article-title":"Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid","volume":"55","author":"Webster","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0044","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acschemneuro.7b00385","article-title":"Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation","volume":"9","author":"Hou","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0045","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1039\/D0OB00126K","article-title":"(18)F-Labeled dihydromethidine: positron emission tomography radiotracer for imaging of reactive oxygen species in intact brain","volume":"18","author":"Egami","year":"2020","journal-title":"Org Biomol Chem"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0046","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1074\/jbc.M116.761536","article-title":"Assessing oxidative stress in tumors by measuring the rate of hyperpolarized [1-13C]dehydroascorbic acid reduction using 13C magnetic resonance spectroscopy","volume":"292","author":"Timm","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0047","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/cn400159h","article-title":"Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson's disease, using mito-TEMPO","volume":"4","author":"Zhelev","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0048","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67336-4","article-title":"Oxidative stress evaluation of skeletal muscle in ischemia-reperfusion injury using enhanced magnetic resonance imaging","volume":"10","author":"Kuroda","year":"2020","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0049","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/cmdc.201402034","article-title":"Redox- and hypoxia-responsive MRI contrast agents","volume":"9","author":"Do","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0050","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.2967\/jnumed.113.129254","article-title":"Potential Clinical Applications of PET\/MR Imaging in Neurodegenerative Diseases","volume":"55","author":"Drzezga","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0051","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1248\/bpb.17.701","article-title":"Cu-ATSM, an intracellular-accessible superoxide dismutase (SOD)-like copper complex: evaluation in an ischemia-reperfusion injury model","volume":"17","author":"Wada","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0052","doi-asserted-by":"crossref","first-page":"44035","DOI":"10.1074\/jbc.M111.274407","article-title":"Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model","volume":"286","author":"Soon","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042277","article-title":"Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes","volume":"7","author":"Parker","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0054","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","article-title":"Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"34","author":"Roberts","year":"2014","journal-title":"J Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0055","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1038\/s41598-024-55832-w","article-title":"Evidence for disrupted copper availability in human spinal cord supports Cu(II)(atsm) as a treatment option for sporadic cases of ALS","volume":"14","author":"Hilton","year":"2024","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","article-title":"Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD","volume":"89","author":"Williams","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0057","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20112285","article-title":"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease","volume":"209","author":"Hung","year":"2012","journal-title":"J Exp Med"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0058","article-title":"Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm)","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0059","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bph.14881","article-title":"Cu(II) (atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jnr.10107","article-title":"Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis","volume":"67","author":"Cassina","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0061","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fnins.2018.00668","article-title":"Cu(II)(atsm) Attenuates Neuroinflammation","volume":"12","author":"Choo","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0062","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13311-016-0504-9","article-title":"The copper bis(thiosemicarbazone) complex Cu(II)(atsm) is protective against cerebral ischemia through modulation of the inflammatory milieu","volume":"14","author":"Huuskonen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0063","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/acschemneuro.3c00743","article-title":"Patient-derived blood-brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer's disease","volume":"15","author":"Wasielewska","year":"2024","journal-title":"ACS Chem Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810722","article-title":"Novel Anti-neuroinflammatory properties of a thiosemicarbazone-pyridylhydrazone copper(II) complex","volume":"23","author":"Choo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/jnc.15609","article-title":"Copper bis(thiosemicarbazone) complexes modulate P-glycoprotein expression and function in human brain microvascular endothelial cells","volume":"162","author":"Pyun","year":"2022","journal-title":"J Neurochem"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0066","article-title":"Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics","volume":"16","author":"Perez-Arancibia","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0067","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12919","article-title":"Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS","volume":"49","author":"Yang","year":"2023","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1053\/j.semnuclmed.2025.03.008_bib0068","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12938","article-title":"Cu(II)(ATSM) significantly decreases microglial reactivity in patients with sporadic amyotrophic lateral sclerosis","volume":"49","author":"Liddell","year":"2023","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299825000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:41:34Z","timestamp":1777380094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299825000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0001299825000352"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.03.008","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CuII-bis(thioureido) Complex: A Potential Radiotracer for Detecting Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}